Rep. David Taylor Sells Lam Research Corporation (NASDAQ:LRCX) Shares

Representative David Taylor (R-Ohio) recently sold shares of Lam Research Corporation (NASDAQ:LRCX). In a filing disclosed on February 02nd, the Representative disclosed that they had sold between $1,001 and $15,000 in Lam Research stock on January 16th. The trade occurred in the Representative’s “DAVID TAYLOR TRUST > SARDINIA READY MIX 401(K) – DAVE” account.

Representative David Taylor also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 1/29/2026.
• Purchased $1,001 – $15,000 in shares of Broadcom (NASDAQ:AVGO) on 1/29/2026.
• Sold $1,001 – $15,000 in shares of Amgen (NASDAQ:AMGN) on 1/29/2026.
• Sold $1,001 – $15,000 in shares of Vertex Pharmaceuticals (NASDAQ:VRTX) on 1/29/2026.
• Purchased $1,001 – $15,000 in shares of Medpace (NASDAQ:MEDP) on 1/29/2026.
• Purchased $1,001 – $15,000 in shares of Salesforce (NYSE:CRM) on 1/29/2026.
• Purchased $1,001 – $15,000 in shares of Amazon.com (NASDAQ:AMZN) on 1/29/2026.
• Sold $1,001 – $15,000 in shares of Procter & Gamble (NYSE:PG) on 1/29/2026.
• Purchased $1,001 – $15,000 in shares of Installed Building Products (NYSE:IBP) on 1/29/2026.
• Purchased $1,001 – $15,000 in shares of Prologis (NYSE:PLD) on 1/29/2026.

Lam Research Stock Performance

Shares of LRCX stock opened at $230.10 on Wednesday. The firm’s 50 day moving average is $190.60 and its 200 day moving average is $148.53. The stock has a market capitalization of $287.34 billion, a P/E ratio of 47.15, a PEG ratio of 2.59 and a beta of 1.78. Lam Research Corporation has a 12 month low of $56.32 and a 12 month high of $251.87. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The business had revenue of $5.34 billion for the quarter, compared to analysts’ expectations of $5.23 billion. During the same quarter in the previous year, the firm posted $0.91 EPS. The business’s revenue for the quarter was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, sell-side analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current year.

Insiders Place Their Bets

In related news, CFO Douglas R. Bettinger sold 40,080 shares of the business’s stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the sale, the chief financial officer owned 987,237 shares in the company, valued at $148,677,892.20. The trade was a 3.90% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.31% of the stock is owned by insiders.

Hedge Funds Weigh In On Lam Research

Institutional investors have recently made changes to their positions in the stock. PMV Capital Advisers LLC bought a new position in Lam Research in the fourth quarter valued at $25,000. IMG Wealth Management Inc. bought a new stake in Lam Research during the second quarter worth about $26,000. Stance Capital LLC purchased a new position in shares of Lam Research in the 3rd quarter worth about $26,000. Howard Hughes Medical Institute bought a new position in shares of Lam Research during the 2nd quarter valued at about $27,000. Finally, Triumph Capital Management bought a new position in shares of Lam Research during the 3rd quarter valued at about $27,000. Institutional investors own 84.61% of the company’s stock.

Key Lam Research News

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Company leadership changes intended to accelerate AI‑era execution — Lam promoted two senior leaders to increase velocity as it leans into AI-driven demand, a governance move investors typically view as supportive for execution and strategy. Lam Research Announces Leadership Transitions to Increase Company Velocity for the AI era
• Positive Sentiment: Cadence CEO Anirudh Devgan added to the board — brings software/EDA and customer insight, which strengthens board expertise as Lam targets AI and advanced-node investments. Lam Research Appoints Cadence CEO Anirudh Devgan to Board of Directors
• Positive Sentiment: Expanded R&D partnership with CEA‑Leti to accelerate specialty technologies and AI‑focused chip work — supports Lam’s longer‑term TAM expansion into MEMS, photonics, sensors and other specialty devices that benefit from advanced deposition/etch equipment. Lam Research and CEA-Leti Expand Research and Development Collaboration to Advance Fabrication of Specialty Technologies
• Positive Sentiment: Analyst price‑target lifts are supporting the bull case — Argus raised its target to $280 and B. Riley raised/ reiterated a higher target (to $310), signaling strong analyst confidence that could underpin shares over time. Argus Research Adjusts Lam Research Price Target to $280 B. Riley Lifts PT on Lam Research to $310
• Neutral Sentiment: Analytical pieces on international revenue trends and Wall Street sentiment — useful context for modeling growth and geographic exposure but not immediate catalysts. Don’t Overlook Lam Research (LRCX) International Revenue Trends While Assessing the Stock
• Neutral Sentiment: Long‑term performance retrospectives and modest PT moves — articles highlighting 15‑year returns and a smaller PT raise to $235 provide background for buy‑and‑hold investors but are not near‑term drivers. $100 Invested In Lam Research 15 Years Ago Would Be Worth This Much Today Lam Research Price Target Raised to $235
• Negative Sentiment: Sector/peer commentary (KLA) has introduced confusion and volatility — differing WFE-market definitions and headline interpretations after KLA’s earnings prompted selling in the equipment group, which can drag on Lam even if Lam’s own outlook is strong. KLA Sank After Earnings—Then Analysts Started Raising Targets
• Negative Sentiment: Relative performance concerns — headlines noting Lam underperformed some peers recently can trigger short‑term profit‑taking and pressure the stock while investors reconcile earnings/guidance with peer messaging. Lam Research Corp. stock underperforms Monday when compared to competitors despite daily gains

Analysts Set New Price Targets

LRCX has been the topic of a number of analyst reports. JPMorgan Chase & Co. increased their price objective on Lam Research from $165.00 to $300.00 and gave the stock an “overweight” rating in a report on Thursday, January 29th. Citigroup upped their price target on Lam Research from $265.00 to $300.00 and gave the company a “buy” rating in a research report on Thursday, January 29th. Weiss Ratings reissued a “buy (b)” rating on shares of Lam Research in a report on Monday, December 29th. HSBC boosted their price objective on shares of Lam Research from $181.00 to $221.00 and gave the company a “hold” rating in a research note on Friday, January 30th. Finally, Citic Securities upped their target price on shares of Lam Research from $165.00 to $275.00 and gave the stock a “buy” rating in a report on Friday, January 30th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $243.32.

About Representative Taylor

David Taylor (Republican Party) is a member of the U.S. House, representing Ohio’s 2nd Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Taylor (Republican Party) ran for election to the U.S. House to represent Ohio’s 2nd Congressional District. He won in the general election on November 5, 2024.

David Taylor graduated from Amelia High School. Taylor earned degrees from Miami University (Ohio) and the University of Dayton School of Law. Taylor’s career experience includes working as an attorney and as a businessman at Sardinia Ready Mix, Inc.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.